KFDA drafted revised standards for new drug re-examination.

Published: 1999-12-20 13:18:00

Updated: 1999-12-20 13:18:00

In order to prepare the official drug re-examination service by product to be filed from 1999, the KFDA announced a draft of the revised standards for new drug re-examination on Dec. 15, which was supplemented to partial problems and institutional inertia found and raised in reviewing process of ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK